Literature DB >> 15298569

Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma.

Y J Suh1, S H Yoon, A P Sampson, H J Kim, S H Kim, D H Nahm, C H Suh, H S Park.   

Abstract

BACKGROUND: Nasal polyps infiltrated with eosinophils are commonly found in chronic asthmatic patients, more frequently in those with aspirin-intolerant asthma (AIA) than aspirin-tolerant asthma (ATA). Some studies have suggested a contribution of superantigens derived from Staphylococcus sp to nasal polyposis and eosinophilia, but their relative importance in AIA and ATA subjects is unknown.
OBJECTIVE: We investigated whether local production of specific IgE to staphylococcal enterotoxins A and B (SEA and SEB) and relationships with markers of eosinophilic inflammation differ in the nasal polyps of AIA and ATA subjects.
METHODS: Fifteen AIA subjects with positive responses to lysine-aspirin bronchoprovocation and 15 ATA subjects underwent polypectomy. Immunoassays were used to quantify eosinophil cationic protein (ECP), IL-5, mast cell tryptase, soluble IL-2 receptors (sIL-2R), total IgE, and specific IgE for SEA and SEB.
RESULTS: ECP levels in nasal polyp homogenates were higher in AIA subjects than in ATA subjects (P < 0.02), with no significant differences in tryptase, IL-5 or sIL-2R. Total IgE, and specific IgE to both SEA and SEB, were detectable in some nasal polyps from both subject groups, but median levels were markedly higher in AIA subjects than in ATA subjects (P = 0.04, 0.01, 0.05, respectively). Levels of specific IgE to SEA and SEB correlated significantly with levels of ECP and IL-5, but not those of tryptase or sIL-2R.
CONCLUSION: These findings suggest that staphylococcal superantigens may drive local eosinophilic inflammation in nasal polyp tissue, and that this is exacerbated in subjects with AIA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15298569     DOI: 10.1111/j.1365-2222.2004.02051.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  17 in total

1.  Staphylococcal enterotoxin B induced expression of IL-17A in nasal epithelial cells and its association with pathogenesis of nasal polyposis.

Authors:  Jun Jin; Young Hoon Yoon; Seo Young Kwak; Ki-Sang Rha; Yong Min Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-14       Impact factor: 2.503

Review 2.  Aspirin-exacerbated respiratory disease and current treatment modalities.

Authors:  Emine Güven Sakalar; Nuray Bayar Muluk; Murat Kar; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-18       Impact factor: 2.503

Review 3.  Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis.

Authors:  Whitney W Stevens; Robert P Schleimer
Journal:  Immunol Allergy Clin North Am       Date:  2016-09-13       Impact factor: 3.479

4.  Clinical significance of eosinophilic cationic protein levels in nasal secretions of patients with nasal polyposis.

Authors:  Dong-Il Sun; Young-Hoon Joo; Hyeon-Jin Auo; Jun-Myung Kang
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-26       Impact factor: 2.503

Review 5.  Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  Immunol Allergy Clin North Am       Date:  2012-12-23       Impact factor: 3.479

Review 6.  Genetic variability of the high-affinity IgE receptor alpha-subunit (FcepsilonRIalpha).

Authors:  Daniel P Potaczek; Chiharu Nishiyama; Marek Sanak; Andrew Szczeklik; Ko Okumura
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

7.  Rhinosinusitis and aspirin-exacerbated respiratory disease.

Authors:  Maria L Garcia Cruz; M Alejandro Jimenez-Chobillon; Luis M Teran
Journal:  J Allergy (Cairo)       Date:  2012-07-04

Review 8.  Update on recent advances in the management of aspirin exacerbated respiratory disease.

Authors:  Nami Shrestha Palikhe; Joo-Hee Kim; Hae-Sim Park
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

9.  A genetic effect of IL-5 receptor α polymorphism in patients with aspirin-exacerbated respiratory disease.

Authors:  Purevsuren Losol; Seung-Hyun Kim; Yoo Seob Shin; Young Min Ye; Hae-Sim Park
Journal:  Exp Mol Med       Date:  2013-03-08       Impact factor: 8.718

10.  IL-5 Promoter Polymorphism Enhances IgE Responses to Staphylococcal Superantigens in Adult Asthmatics.

Authors:  Purevsuren Losol; Seung-Hyun Kim; Eui-Kyung Hwang; Yoo Seob Shin; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2012-09-20       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.